(PhysOrg.com) -- A new molecule important in a part of the memory that allows recognition of people has been identified by researchers at the University of Bristol. This type of memory is impaired at an early stage during Alzheimer’s disease and so it is hoped that understanding the funct...
New insight into Alzheimer's disease. (includes information about tacrine)
Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/‘proxy’...
Italy. Here, the lectures of M. Racchi on History and future perspectives of Alzheimer Biomarkers and of G. Scapagnini on Cellular Stress Response and Brain Ageing are summarized. Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease, which in ...
“This is an observational study, so we can’t say that ‘a causes b’,” he said. “But we can say that they unfold at the same time, and it’s possible that the same pathologies may contribute to both.” Alzheimer’s disease is caused by the accumulation of two proteins, amyloid...
There has been unprecedented growth of scientific knowledge about Alzheimer's disease (AD), The description of distinctive and reliable biomarkers that are now available through structural brain imaging with magnetic resonance imaging, molecular neuroimaging with positron emission tomography, and cerebrospinal...
Alzheimer’s disease is the most common form of dementia, in which people become forgetful and confused, usually starting in older age. People with the disease have a build-up of two kinds of protein clumps in the brain: amyloid and tau.
Alzheimer's disease is a devastating brain illness that affects an estimated 47m people worldwide. It is the most common cause of dementia in the Western world. Despite this, there are currently no treatments that are effective in curing Alzheimer's disease or preventing its relentless ...
Alzheimer's Disease (AD) is a highly complex disease involving a broad range of clinical, cellular, and biochemical manifestations that are currently not understood in combination. This has led to many views of AD, e.g. the amyloid, tau, presenilin, oxidative stress, and metal hypotheses. The...
Alzheimer’s disease (AD) is the leading cause of dementia. The two histopathological markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and neurofibrillary tangles of aggregated, abnormally hyperphosphorylated tau protein. The m